銅冠銅箔(301217.SZ):網上路演時間為1月17日14:00-17:00
格隆匯1月13日丨銅冠銅箔(301217.SZ)公佈首次公開發行股票並在創業板上市網上路演公吿,為了便於社會公眾投資者瞭解發行人的基本情況、發展前景和本次發行申購的相關安排,發行人和聯席主承銷商將就本次發行舉行網上路演。
1、網上路演時間:2022年1月17日(週一)14:00-17:00;
2、網上路演網址:
中國證券報·中證網(網址:http://www.cs.com.cn/roadshow),
全景路演(網址:http://rs.p5w.net);
3、參加人員:發行人管理層主要成員和聯席主承銷商相關人員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.